Mental health
-
DATABASE (341)
-
ARTICLES (198)
Rick Klausner is an award-winning scientist, former executive director of the Bill & Melinda Gates Foundation and an entrepreneur. Cell and molecular biologist Klausner was also director of the US National Cancer Institute from 1999-2001 and currently serves as CEO at biotech Lyell Immunopharma working with cell-based technology. He has also co-founded three US healthcare startups to date, Juno Therapeutics in 2013, MindStrong Health in 2014 and GRAIL in 2015. In 2021, he participated as an investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Rick Klausner is an award-winning scientist, former executive director of the Bill & Melinda Gates Foundation and an entrepreneur. Cell and molecular biologist Klausner was also director of the US National Cancer Institute from 1999-2001 and currently serves as CEO at biotech Lyell Immunopharma working with cell-based technology. He has also co-founded three US healthcare startups to date, Juno Therapeutics in 2013, MindStrong Health in 2014 and GRAIL in 2015. In 2021, he participated as an investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Founded in 2009, Finnish VC Lifeline Ventures has invested in over 100 early-stage startups, with investments ranging from €100,000 to €2m. Focusing mainly on local tech startups, the VC has 71 tech and non-tech companies in its portfolio.Recent investments in April 2021 include the $100m Series C round of Finnish wellness ring and app Oura Health and the $6.2m seed round of Finnish cleantech Carbo Culture. One of Lifeline’s VC partners, Timo Ahopelto, is an advisor at student-led VC Wave Ventures that also participated in the investment round of Carbo Culture.
Founded in 2009, Finnish VC Lifeline Ventures has invested in over 100 early-stage startups, with investments ranging from €100,000 to €2m. Focusing mainly on local tech startups, the VC has 71 tech and non-tech companies in its portfolio.Recent investments in April 2021 include the $100m Series C round of Finnish wellness ring and app Oura Health and the $6.2m seed round of Finnish cleantech Carbo Culture. One of Lifeline’s VC partners, Timo Ahopelto, is an advisor at student-led VC Wave Ventures that also participated in the investment round of Carbo Culture.
Knokcare (formerly Knok Healthcare)
After disrupting Portugal’s public healthcare system with video consultations via app, Knokcare is offering its SaaS services to health insurers in Europe and beyond.
After disrupting Portugal’s public healthcare system with video consultations via app, Knokcare is offering its SaaS services to health insurers in Europe and beyond.
CTO and co-founder of IOMED Medical Solutions
Gabriel de Maeztu is CTO and co-founder of IOMED Medical Solutions, which facilitates data extraction from electronic health records (EHR) and where he has worked since 2016. He had the idea for the software in 2014 and worked on it from then, completing two internships during that time: at QMENTA, formerly Mint Labs, a US drug development startup dedicated to brain diseases (where he worked in data science) and at Barcelona bioresearch center IDIBAPS in neuro-imaging research.De Maeztu holds a doctorate in Medicine from the International University of Catalonia, where he first had the idea for IOMED. He also holds a bachelor’s in Mathematics and a postgraduate qualification in Data Processing, Data Science and Big Data. He was also previously a developer at Barcelona tech agency Chroma Branding.
Gabriel de Maeztu is CTO and co-founder of IOMED Medical Solutions, which facilitates data extraction from electronic health records (EHR) and where he has worked since 2016. He had the idea for the software in 2014 and worked on it from then, completing two internships during that time: at QMENTA, formerly Mint Labs, a US drug development startup dedicated to brain diseases (where he worked in data science) and at Barcelona bioresearch center IDIBAPS in neuro-imaging research.De Maeztu holds a doctorate in Medicine from the International University of Catalonia, where he first had the idea for IOMED. He also holds a bachelor’s in Mathematics and a postgraduate qualification in Data Processing, Data Science and Big Data. He was also previously a developer at Barcelona tech agency Chroma Branding.
Alta Life Sciences (Alta LS) was established in 2016. Based in Barcelona, the management team is led by the co-founder of Alta Partners Guy Paul Nohra, a leading pioneer VC in life sciences. Alta Partners has funded over 150 companies since 1996. Alta LS specializes in the life sciences sector in Spain and abroad, targeting biotech, genomics, medical devices, diagnostics and digital health. It also acts as a bridge fund, connecting the Spanish life sciences ecosystem to VC experts in Silicon Valley. Investment is available for all stages of development, with focus mainly on seed and Series A funding.
Alta Life Sciences (Alta LS) was established in 2016. Based in Barcelona, the management team is led by the co-founder of Alta Partners Guy Paul Nohra, a leading pioneer VC in life sciences. Alta Partners has funded over 150 companies since 1996. Alta LS specializes in the life sciences sector in Spain and abroad, targeting biotech, genomics, medical devices, diagnostics and digital health. It also acts as a bridge fund, connecting the Spanish life sciences ecosystem to VC experts in Silicon Valley. Investment is available for all stages of development, with focus mainly on seed and Series A funding.
Founded in 2002, Bluesail was initially known as a manufacturer of PVC gloves, with an annual capacity of tens of billions of pairs at its peak. At the end of 2012, it began to expand into more health-related areas.In 2018, it acquired a 93.37% stake in Biosensors International Group that specializes in developing, manufacturing and licensing technologies for use in interventional cardiology procedures and critical care. The two companies were merged and Bluesail began to produce more high-end medical consumables. In 2019, the company and senior executives invested in CH Biomedical to collaborate in the development of innovative medical devices for sale in China and overseas.
Founded in 2002, Bluesail was initially known as a manufacturer of PVC gloves, with an annual capacity of tens of billions of pairs at its peak. At the end of 2012, it began to expand into more health-related areas.In 2018, it acquired a 93.37% stake in Biosensors International Group that specializes in developing, manufacturing and licensing technologies for use in interventional cardiology procedures and critical care. The two companies were merged and Bluesail began to produce more high-end medical consumables. In 2019, the company and senior executives invested in CH Biomedical to collaborate in the development of innovative medical devices for sale in China and overseas.
Based in San Francisco, Slow Ventures was founded in 2011 by an early Facebook employee David Morin, who helped to build the Facebook Platform and Facebook Connect. Slow Ventures is no longer known as the “Facebook Alumni Fund”.Today, the VC is a generalist fund, investing in diverse sectors worldwide, ranging from digital health to enterprise solutions. The firm has backed unicorn startups in the US like Postmates, Nextdoor, AngelList and Evernote. A fourth fundraising round has been launched for two new funds totaling $220m: seed funding of $165m and $55m for a follow-up round. Its last funding round closed at $145m in 2016.
Based in San Francisco, Slow Ventures was founded in 2011 by an early Facebook employee David Morin, who helped to build the Facebook Platform and Facebook Connect. Slow Ventures is no longer known as the “Facebook Alumni Fund”.Today, the VC is a generalist fund, investing in diverse sectors worldwide, ranging from digital health to enterprise solutions. The firm has backed unicorn startups in the US like Postmates, Nextdoor, AngelList and Evernote. A fourth fundraising round has been launched for two new funds totaling $220m: seed funding of $165m and $55m for a follow-up round. Its last funding round closed at $145m in 2016.
Green Monday Ventures is the impact investment arm of Green Monday Group founded by longtime Buddhist David Yeung to produce plant-based meat and operate Hong Kong’s first plant-based concept store.Founded in 2012, the Green Monday movement is a social enterprise aimed at promoting sustainable lifestyle concepts like "green food" to address challenges relating to public health, climate change, food security and animal wellbeing. The Hong Kong-based VC was set up in 2013 to focus on investments in alternative protein companies worldwide.
Green Monday Ventures is the impact investment arm of Green Monday Group founded by longtime Buddhist David Yeung to produce plant-based meat and operate Hong Kong’s first plant-based concept store.Founded in 2012, the Green Monday movement is a social enterprise aimed at promoting sustainable lifestyle concepts like "green food" to address challenges relating to public health, climate change, food security and animal wellbeing. The Hong Kong-based VC was set up in 2013 to focus on investments in alternative protein companies worldwide.
Founded in 2020 in Boulder, Colorado, Trailhead Capital is a specialist agtech and foodtech investor that focuses on startups in the US, Canada, Australia and Israel. The VC’s regenerative agriculture portfolio includes investments in food ingredients traceability, food supply chains, reducing food waste and soil health environmental management.Recent investments include in the $12m Series A round of Vence, a US-based producer of virtual fencing wearables for livestock management in May 2021. In February 2021, it also participated in the $6m funding round of foodtech HowGood that specializes in rating the sustainability of grocery products.
Founded in 2020 in Boulder, Colorado, Trailhead Capital is a specialist agtech and foodtech investor that focuses on startups in the US, Canada, Australia and Israel. The VC’s regenerative agriculture portfolio includes investments in food ingredients traceability, food supply chains, reducing food waste and soil health environmental management.Recent investments include in the $12m Series A round of Vence, a US-based producer of virtual fencing wearables for livestock management in May 2021. In February 2021, it also participated in the $6m funding round of foodtech HowGood that specializes in rating the sustainability of grocery products.
Co-founder of Waterdrop and general manager of Shuidi Chou of Waterdrop (Shuidi)
Xu Hanhan graduated from the Guanghua School of Management, Peking University, in 2008. She then worked at the VC, China Renaissance Capital Investment, and later became personal assistant to ByteDance CEO and founder Zhang Yiming during the startup's early years. She co-founded Waterdrop in 2016 and is now in charge of Waterdrop Crowdfunding. She also started another of Waterdrop's platforms, Waterdrop Public Wellness, which helps charitable organizations fundraise as well as report on the usage of the funds received.
Xu Hanhan graduated from the Guanghua School of Management, Peking University, in 2008. She then worked at the VC, China Renaissance Capital Investment, and later became personal assistant to ByteDance CEO and founder Zhang Yiming during the startup's early years. She co-founded Waterdrop in 2016 and is now in charge of Waterdrop Crowdfunding. She also started another of Waterdrop's platforms, Waterdrop Public Wellness, which helps charitable organizations fundraise as well as report on the usage of the funds received.
CTO and co-founder of HumanITcare
Sanchez is a computer and data science expert with a master’s degree in innovation and research in informatics with specialization in advanced computing from the Polytechnic University of Barcelona (UPC). He also holds multiple certifications from the John Hopkins University School of Education. Sanchez is currently CTO and co-founder of HumanITcare, a telemedicine platform for remote patient monitoring using real-world data and AI to treat patients affected by chronic diseases and also to accelerate drug development and clinical trials. Prior to HumanITcare, Sanchez worked as Data Scientist in a joint-project between the Spanish insurance company Catalana Occidente and technology consultancy Raona to develop a sales collaborative platform. He has also worked on projects in software development, mobile apps, server and hardware as well as prototyping for IoT devices in the fields of education, health and wellness.
Sanchez is a computer and data science expert with a master’s degree in innovation and research in informatics with specialization in advanced computing from the Polytechnic University of Barcelona (UPC). He also holds multiple certifications from the John Hopkins University School of Education. Sanchez is currently CTO and co-founder of HumanITcare, a telemedicine platform for remote patient monitoring using real-world data and AI to treat patients affected by chronic diseases and also to accelerate drug development and clinical trials. Prior to HumanITcare, Sanchez worked as Data Scientist in a joint-project between the Spanish insurance company Catalana Occidente and technology consultancy Raona to develop a sales collaborative platform. He has also worked on projects in software development, mobile apps, server and hardware as well as prototyping for IoT devices in the fields of education, health and wellness.
Castel Capital is a privately-owned Dutch venture capital and equity platform. The company also works with co-investors and private family offices to build bespoke investment portfolios. Castel focuses on both tech and non-tech business opportunities across Europe. Seed funding of €100,000–€500,000 and Series A rounds of €500,000–€1 million are generally available for tech deals. Castel has a hands-on management approach and seeks to add value to the portfolio companies. The firm has invested in 10 startups in diverse sectors like digital health, fintech and transportation.
Castel Capital is a privately-owned Dutch venture capital and equity platform. The company also works with co-investors and private family offices to build bespoke investment portfolios. Castel focuses on both tech and non-tech business opportunities across Europe. Seed funding of €100,000–€500,000 and Series A rounds of €500,000–€1 million are generally available for tech deals. Castel has a hands-on management approach and seeks to add value to the portfolio companies. The firm has invested in 10 startups in diverse sectors like digital health, fintech and transportation.
Vesalius Biocapital III is a €70 million fund that invests in medtech, e-health initiatives and drug development in Europe. It was launched in 2017 by Luxembourg-based Vesalius Biocapital, a life sciences venture capital firm founded in 2007. Preceding Vesalius Biocapital III were Vesalius Biocapital I, with €76 million under management and Vesalius Biocapital II, which has €78 million invested; both funds have 11 portfolio companies each.Its recent investments include in Portuguese home physiotherapy tech solution SWORD Health's 2021 $25m Series B and in the 2020 $9m second phase of its Series A round as well as in the 2020 €22m Series B round of German biotech Topas Therapeutics.
Vesalius Biocapital III is a €70 million fund that invests in medtech, e-health initiatives and drug development in Europe. It was launched in 2017 by Luxembourg-based Vesalius Biocapital, a life sciences venture capital firm founded in 2007. Preceding Vesalius Biocapital III were Vesalius Biocapital I, with €76 million under management and Vesalius Biocapital II, which has €78 million invested; both funds have 11 portfolio companies each.Its recent investments include in Portuguese home physiotherapy tech solution SWORD Health's 2021 $25m Series B and in the 2020 $9m second phase of its Series A round as well as in the 2020 €22m Series B round of German biotech Topas Therapeutics.
Founder and CEO of PesanLab
Dimas Prasetyo is the founder and CEO of PesanLab. He graduated with a degree in Medical Technology and Laboratory Science from Yogyakarta Health Polytechnic. He has over eight years of work experience in marketing, operations and management in the clinical laboratory diagnostics industry. He was also a product specialist at Non-invasive Genetic Abnormalities Test in Your Clinic and at Natera Inc. He co-founded Lab Panorama Bandung in 2009 and left in 2013 to become the founder of LabConX that was later rebranded as PesanLab.
Dimas Prasetyo is the founder and CEO of PesanLab. He graduated with a degree in Medical Technology and Laboratory Science from Yogyakarta Health Polytechnic. He has over eight years of work experience in marketing, operations and management in the clinical laboratory diagnostics industry. He was also a product specialist at Non-invasive Genetic Abnormalities Test in Your Clinic and at Natera Inc. He co-founded Lab Panorama Bandung in 2009 and left in 2013 to become the founder of LabConX that was later rebranded as PesanLab.
CEO and co-founder of String Bio
Ezhil Subbian studied industrial biotechnology at Anna University in India. She then went to the US to complete two PhDs in biochemistry, biophysics and molecular biology at the Oregon Health & Science University and from Rutgers, the State University of New Jersey-New Brunswick. She was a research assistant at both universities.While in the US, she was also a research scientist at Gevo Inc and at Vollum Institute. In 2008, she became a scientist and technical lead at pharma Codexis in California. In 2011, she worked at San Francisco-based Kumar Investments as an entrepreneur and biotech consultant.In 2012, she founded biotech startup String Inc while on a nine-month Startup Leadership Program in Silicon Valley. In June 2013, she and husband returned to India and formed a new company String Bio to continue working on the alternative protein powder project for animal feed production.
Ezhil Subbian studied industrial biotechnology at Anna University in India. She then went to the US to complete two PhDs in biochemistry, biophysics and molecular biology at the Oregon Health & Science University and from Rutgers, the State University of New Jersey-New Brunswick. She was a research assistant at both universities.While in the US, she was also a research scientist at Gevo Inc and at Vollum Institute. In 2008, she became a scientist and technical lead at pharma Codexis in California. In 2011, she worked at San Francisco-based Kumar Investments as an entrepreneur and biotech consultant.In 2012, she founded biotech startup String Inc while on a nine-month Startup Leadership Program in Silicon Valley. In June 2013, she and husband returned to India and formed a new company String Bio to continue working on the alternative protein powder project for animal feed production.
Aimentia: Pioneering mental health AI SaaS seeks to improve diagnosis as demand surges
Barcelona-based Aimentia supports the oft-overlooked mental health segment through digitalization and analytics, going beyond therapy platforms
Mental health services platform Ibunda wants to keep expanding its reach
Since its founding in 2015, the Indonesian startup Ibunda has provided psychological consultations to over 200,000 clients
Mindtera: Building mental resilience through bite-sized lessons
Mindtera wants to nip mental health issues in the bud by equipping working adults with skills to navigate work challenges and personal relationships, using their phones
HumanITcare: The first real-time symptom tracker for mental illness patients
FollowHealth’s HumanITcare app combines wearables, analytics and AI to monitor and improve outcomes for sufferers of depression, schizophrenia, alcoholism and more
TherapyChat: Using AI to scale and improve accuracy in mental health treatment
Business for the Spanish startup has surged ninefold since Covid-19, with the company expanding to the UK and Italy
Gorry Holdings: Promoting staff wellness in Indonesia
The healthtech startup wants companies to understand how healthy employees can translate into good business
Choose from over 10,000 mental health therapists at Yidianling
Startup's 24/7 services will include AI-powered chatbots to help more Chinese cope with mental health issues, amid lack of therapists
Virtuleap's VR games provide a mental workout, boosting brain health
Used by the AARP and Veteran's Health Administration in the US, Virtuleap’s games with AI-enabled assessment work to improve cognition and to counter degenerative diseases such as Alzheimer's
Accelerating Asia bets on unicorn wave from MSME digitalization, logistics
The investor-accelerator’s sixth batch will start accepting applications in December, with greater ESG focus and a pledge to donate 1% of profit on investments to charity
Benergy: A new app to track gut health with smart data
The Benergy app allows results to be shared with doctors to facilitate diagnosis and includes swap tests
China's WeDoctor offers free coronavirus consultations globally in English and Chinese
WeDoctor lets anyone in the world send queries to doctors who fought to save lives in China's most affected Covid-19 districts, and now helping people overseas to stay safe during the pandemic
Startups join the fight in China's coronavirus crisis
Chinese startups have discovered their technologies can play a major role in the nationwide efforts to battle the coronavirus epidemic
HumanITcare: Covid-19 spurs demand for telemedicine across Spain and beyond
The startup’s revenue is expected to exceed €10m by 2024 due to rapid digital transformation of healthcare services and a growing market for AI-powered medtechs
AlphaBeats: a 10-minute music playlist to de-stress your brain using biofeedback
With the exclusive rights to Philips’s neurofeedback technology, Alphabeats has developed an app to offer and enhance relaxation using a person’s favorite music
Virtual Bodyworks: VR psychotherapy to reduce crime and health issues
Applications created by the Barcelona-based startup could be used to track and influence human behavior
Sorry, we couldn’t find any matches for “Mental health”.